This biopharmaceutical company focuses on the discovery, development and commercialization of organ-selective medecins, especially chronic obstructive pulmonary disease (COPD)
This biopharmaceutical company focuses on the discovery, development and commercialization of organ-selective medecins, especially chronic obstructive pulmonary disease (COPD)